Back to Search
Start Over
A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations
- Source :
- Intestinal Research. 20:342-349
- Publication Year :
- 2022
- Publisher :
- Korean Association for the Study of Intestinal Diseases, 2022.
-
Abstract
- Background/Aims: Proinflammatory cytokines released from adipocytes can influence the development, progression, and treatment of inflammatory bowel disease (IBD), and may be associated with worse clinical outcomes. Methods: For 2016–2018, we analyzed data from the Nationwide Inpatient Sample to identify adult (≥18 years) hospitalizations with a primary discharge diagnosis of IBD. The study sample was divided based on the presence or absence of obesity. The primary outcomes included inpatient mortality, while the secondary outcomes consisted of system-based complications and disease implications on the United States healthcare system.Results: We identified 282,005 hospitalizations of IBD from 2016 to 2018. Of these hospitalizations, 26,465 (9.4%) had a secondary diagnosis of obesity while 255,540 (90.6%) served as controls. IBD hospitalizations with obesity had a higher mean age (47.9 years vs. 45.2 years, PPPPP
- Subjects :
- medicine.medical_specialty
business.industry
Gastroenterology
Secondary diagnosis
Disease
medicine.disease
Hospital charge
Obesity
Inflammatory bowel disease
Middle age
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Epidemiology
Cohort
medicine
030211 gastroenterology & hepatology
business
Subjects
Details
- ISSN :
- 22881956 and 15989100
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Intestinal Research
- Accession number :
- edsair.doi.dedup.....52bf02e301b5d545a392424db4c064d9